The New Criterion’s Tim Boreham runs through the options available for investors wishing to add gold exposure to their portfolio
SiteMinder’s March quarter update showed the company is on track to reach positive earnings and cash flow next quarter and new product launches offer growth
Michael Gable of Fairmont Equities has spotted solid support underneath shares in WiseTech Global
A forecast-beating jump in gross margins was the highlight in ResMed’s March quarter result
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
A negative reaction to Brambles’ March quarter update suggests more was expected, but brokers, while split, are mostly positive
Packaging business Orora continues to struggle in the near term, but brokers agree the company’s prospects in the longer term do look promising
The New Criterion’s Tim Boreham uncovers the potential of 4D Medical in the USA
Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements
FNArena’s Monitor keeps track of corporate earnings result releases, including broker views, ratings and target price changes and beat/miss assessments